A patient has died in a clinical trial evaluating a Rocket Pharmaceuticals gene therapy shortly after complications emerged that led the FDA to pause the study. An inquiry into the fatality is ...
A Rocket Pharmaceuticals gene therapy has reached the end of its regulatory journey before receiving an FDA decision. The company has withdrawn the submission for its therapeutic candidate for Fanconi ...
The FDA has slapped a clinical hold on Rocket Pharmaceuticals’ pivotal gene therapy trial in response to a death. Rocket, which was aiming to report data in mid-2026, dropped its targeted trial ...
Hosted on MSN
Quavo and his Rocket Foundation launch “Emergency Therapy Support Fund” after recent Atlanta shootings
In a powerful response to a tragic surge in violence, Quavo and his nonprofit, The Rocket Foundation, have launched an Emergency Therapy Support Fund aimed at helping families impacted by a recent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results